Purpose: The goal of this study is to characterize the genomic landscape of pediatric rheumatological disorders in the Middle East, and to assess the clinical utility of genetic findings in this group of patients. Methods: Seventy-one pediatric patients were clinically and genetically assessed for a spectrum of rheumatology-related disease at the only dedicated tertiary childrens hospital in the United Arab Emirates. Clinical genomic investigations included genotyping, NGS-based gene panels, whole exome sequencing, along with rapid sequencing in the intensive care unit (ICU) and urgent setting. Results: The overall positive yield was 46.5% (18.2%-66.7%), while dual diagnoses were made in 2 cases (6%). Although the majority (21/33, 64%) of positive findings involved the MEFV gene, the remaining (12/33, 36%) alterations were attributed to eleven other genes/loci. Copy number variants contributed substantially (5/33, 15.2%) to the overall diagnostic yield. Sequencing-based testing, specifically rapid sequencing, had high positive rate and delivered timely results. Genetic findings guided clinical management plans and interventions in most cases (27/33, 81.8%). We highlight unique findings and provide additional evidence that heterozygous loss of function of the IFIH1 gene increases susceptibility to recurrent fevers. Conclusion: Our study highlights the importance of comprehensive genomic investigations in patients with pediatric rheumatological disorders.